Dispensing Opioids: Decisions to Improve Medication Safety

Dispensing Opioids: Decisions to Improve Medication Safety

Dispensing opioids from your practice may provide immediate pain relief for your patients. However, dispensing is also accompanied by restrictions and requirements set out by Maryland state law. Prescribers who are dispensing opioids must login and enter data separately to the Prescription Drug Monitoring Program (PDMP). While treatment regularly involves assessment of a patient’s acute and/or chronic pain, other opportunities are presented at the point of dispensing. This includes an opportunity to discuss alternatives to opioid therapy, to assess and manage the risk of these therapies, and discussion of treatment agreements. Using interactive technologies, this module will briefly presents key points regarding counseling patients in safe use and processes to prevent diversion. The dispensing criteria for a legal opioid prescription will be reviewed so as to comply with federal law.

This online course includes a free 60 minute interactive module for dispensing physicians offering guidance in opioid dispensing practices. PDMP step-by-step instructions at the point of dispensing is provided.  This course meets the PDMP training requirements of the Maryland Department of Health and Mental Hygiene.

CE: 2.0 AMA PRA Category 1 CreditTM, 2.0 ACPE Contact Hours
Universal Activity Number (UAN): 0025-0000-17-037-H05-P
Launch Date: 09/16/2017
Expiration Date: 09/06/2020
Course Number: CN#MD006
Target Audience: Physicians, Pharmacists, Dentists
Instructor: Fadia T. Shaya, PhD, MPH and Kate Jackson, MPH

Other modules in this series include:

Learning Objectives

At the end of this application-based activity, the physician prescriber will be able to:

  1. At the point of dispensing, assess and manage risks for patients who are prescribed medically-necessary opioids;
  2. Educate patients to safely use prescription opioids;
  3. Distinguish between opioid misuse and diversion prevention strategies; and
  4. Properly process prescriptions in the PDMP at the point of dispensing.

Your Instructor

Fadia T. Shaya
Professor, Department of Pharmaceutical Health Services Research
University of Maryland School of Pharmacy

View Bio

Kate Jackson
PDMP Manager
Maryland Behavioral Health Administration, DHMH

Technology Requirements

Unless otherwise noted in the course materials, the following are required to access online courses: A computer or mobile device with a stable internet connection; a current internet browser, such as Google Chrome, Microsoft Internet Explorer, Mozilla® Firefox, or Apple® Safari that supports the Adobe® Flash® Player; a PDF Viewer; and the ability to view and update Microsoft Word® and PowerPoint® documents.

 

Successful Completion requires the learner to complete all practice based activity components including the audiovisual presentations, post-test, and activity evaluation. Participants must receive a score of at least 70% on the post-test in order to receive credit. The post-test may be taken up to three (3) times. Learners must complete the activity evaluation in order to receive CE credit.  A link to the activity evaluation will be available once a learner has successfully completed all other course segments.

Disclosure and Transparency in CME/CPD:
It is MedChi’s policy to ensure the independence, transparency, balance, objectivity, scientific rigor and integrity, as well as validation of content for all CME/CPD activities we accredit. To that end, faculty must disclose to the participants any relationships with companies identified as meeting the ACCME definition of a commercial interest. In the process of the disclosure process, all faculty and planners have disclosed the presences or absence of such relationships to MedChi. MedChi has identified, evaluated and where appropriate, attempted to resolve any potential conflicts of interest. This is done through the use of content validation, the use of evidence-based data, and multi-disciplinary peer review. The information provided as disclosure to the learner, is to inform the learner and aide in judgment, not to imply that disclosed relationships will have a negative effect on a presentation.

Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MedChi, The Maryland State Medical Society, and The University of Maryland School of Pharmacy. MedChi is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statements:
Dispensing Opioids: Decisions to Improve Medication Safety
MedChi designates this online educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Maryland Prescription Drug Monitoring Program
MedChi designates this online educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Credit: In order to receive CME credit for participation in these modules the learner is required to complete a post-test and achieve a score of 70% or higher for each module.

Conflict of Interest Disclosure: In accordance with the University of Maryland School of Pharmacy Policy on Conflicts of Interest, faculty certify that they had no potential conflicts of interest while developing the materials for this program.

Privacy and Confidentiality:

The University of Maryland School of Pharmacy is committed to protecting the privacy of our learners. All enrollees are protected under The Family Educational Rights and Privacy Act (20 U.S.C. § 1232g; 34 CFR Part 99) (FERPA). The UMB Policy on Confidentiality and Disclosure of Student Records can be found at: https://www.umaryland.edu/policies-and-procedures/library/academic-affairs/policies/iii-630a.php.   

In order to submit your continuing education credit to a professional accrediting body, we must collect personal information including, but not limited to, name, NABP ID, and date of birth. When you request continuing education credits, certain personal information will be provided to the professional certifying entity in order to issue Certificates of Credit. 

Copyright:  Resources are provided for the educational benefit of our learners and are not for distribution. All information and materials provided are the property of and have been prepared by the University of Maryland Baltimore or have been granted permission for use by the copyright owner.  No portion of this module may be reproduced or transmitted without written permission.  All rights reserved. 

The University of Maryland School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.



 

Refund Policy
  • A refund, less a $75 administration fee, will be made if cancellations are requested within 15 days of purchase. Other restrictions may apply.
  • Refund requests must be submitted in writing to CEHelp@rx.umaryland.edu.
  • Refunds are not available in the following circumstances:
    • A learner has logged into a course or series;
    • Has launched course materials;
    • Course materials have been shipped; or
    • Request is made after 15 days of the ordering date.
  • Course registrations are non-transferrable.

Questions?  Review the Frequently Asked Questions page.  Can't find what you are looking for?  Contact Customer Service at CEHelp@rx.umaryland.edu or 410-706-3381.